CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Designed to provide broad exposure to the Style Box - Large Cap Growth category of the market, the First Trust Growth Strength ETF (FTGS) is a smart beta exchange traded fund launched on 10/25/2022.

UK remained focused on artificial intelligence (AI) and cryptocurrency in February, despite market volatility, according to the platform’s latest trading data.